Skip to content
June 1, 2023
  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Reddit
  • Telegram
  • TikTok
  • LinkedIn
  • Discord
Orinoco Tribune – News and opinion pieces about Venezuela and beyond

Orinoco Tribune – News and opinion pieces about Venezuela and beyond

From Venezuela and made by Venezuelan Chavistas

Primary Menu
  • News
  • Opinion
  • About us
    • About us
    • Who we are – Becoming a Volunteer
    • Editorial guidelines for contributors
    • Our Sources
      • Venezuelan Sources
      • International Sources
    • Contact us
  • Categories
    • Politics
    • Economy
    • Security and Defense
    • International
      • Africa
      • Asia
      • Europe
      • Oceania
      • US/Canada
    • Latin America and ALBA-TCP
      • South America
      • Central America and the Caribbean (+Mexico)
    • Ideology-Commune-Labor
    • Health-Education-Sport-Culture-Technology
    • Solidarity and Social Movements
    • OT Specials
  • Support Us
Light/Dark Button
YouTube Channel
  • Home
  • News
  • Pfizer Prioritizes Profits over People, Refuses to Release COVID-19 Vaccine Patent
  • International
  • News

Pfizer Prioritizes Profits over People, Refuses to Release COVID-19 Vaccine Patent

May 8, 2021

German pharmaceutical corporation Pfizer has flatly rejected to give consent to the proposal of a temporary lift in patent protections for Covid-19 vaccines. There is an increasing demand on the international level to remove patents temporarily for Covid-19 vaccines so as to respond more efficiently to the current pandemic.

Albert Bourla, 59-year-old Greek veterinarian and CEO of the European firm which also has base in the United States, gave a statement to international news agencies, in which he expressed that he was not “at all” in favor of such a measure.

Instead, Bourla suggested increasing the production of the existing Covid-19 vaccine formula that Pfizer created in conjunction with German company BioNtech. This is obviously a part of the marketing scheme that the company has maintained since the launch of its product at the end of 2020.

Que dice Pfizer que no, que ellos quieren cobrar sus vacunas. Que la salud y la vida de sus consumidores de fármacos no importa, si no las ganancias y la salud financiera de sus accionistas. https://t.co/cRJie7pp9q

— William Castillo Bollé (@planwac) May 6, 2021

RELATED CONTENT:Socialists for Mandatory COVID-19 Vaccines

The vaccine patent waiver proposal has received even the support of the US government. Some Washington spokespersons clarified that, although the US government supports the protection of intellectual property, the Biden administration considers the patent waiver measure as necessary to stop the spread of the pandemic.

However, the World Trade Organization (WTO) disagrees with lifting patent protections. It considers the measure as “counterproductive” for firms that have an interest in “investing“ in the innovation of coronavirus immunization related products.

Pfizer takes care of its business interests
Pfizer CEO Bourla recently stated that he was “very proud of the way we [Pfizer] have positioned ourselves in 2021, with strong financial results in the first quarter.”

For this same reason, Pfizer’s board of directors publicly stated this week that, among the company’s business projections, it aims to gain record revenues of approximately $26 billion with the sale of its COVID-19 vaccine.

 

RELATED CONTENT: Pharmaceutical Industry Dispatches Army of Lobbyists to Block Generic COVID-19 Vaccines

Consequently, the company raised its revenue expectations by 73%, with respect to what the multinational had foreseen at the beginning of the commercialization of its vaccine. It has been, likewise, disclosed that in the first quarter of 2021, Pfizer’s earnings stand at $3.4 billion.

Considering this, the Pfizer shareholders’ refusal to lift patent protections was to be expected; and instead of assisting vulnerable countries with low access to vaccines, they have insisted on prioritizing their company’s income.

Moreover, if the concrete numbers were to be scrutinized, according to figures published by the firm itself, Pfizer’s vaccine business has set gross revenue for this year at a minimum of $70.5 billion. This would be well above the $59,400 million mark that the company had established as floor price at the beginning of its production cycle.

 

Featured Images: Profits over vaccination – CEO of Pfizer rejects patent waiver. Photo: Drew Angerer / Getty Images.

(RedRadioVe) by José Manuel Blanco Díaz

Translation: Orinoco Tribune

OT/GMS/SC

Don't want to be a victim of the Algorithm?

SIGN UP TO RECEIVE OUR WEEKLY DIGEST WITH ALL YOU NEED TO KNOW ABOUT VENEZUELA AND BEYOND

We don’t spam! Read our privacy policy for more info.

orinocotribune
Website | + posts
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    Venezuelan President Nicolás Maduro chairing a meeting with security and emergency response staff to address and respond to the beginning of the rainy season. Photo: Presidential Press.
    May 31, 2023
    President Maduro: 'We Are Working as Single Entity to Respond to Rainy Season'
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    Bolivian President Luis Arce (left), Venezuelan President Nicolás Maduro (center) and Brazilian President Lula da Silva (right) preparing to take a photo at the South American Summit at the Itamaraty Palace in Brasília, Brazil, on Tuesday, May 30, 2023. Photo: AP/Andre Penner.
    May 31, 2023
    President Maduro Advances Busy Agenda in Brazil (+Argentina's Statements)
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    Venezuelan President Nicolás Maduro making the victory sign during the South American Summit of Presidents in Brazil on Tuesday, May 30, 2023. Photo: André Borges/EFE.
    May 31, 2023
    President Maduro: South America Advances Towards New Stage of Unity in Diversity
  • orinocotribune
    https://orinocotribune.com/author/orinocotribune/
    President of Venezuela's National Assembly, PSUV Deputy Jorge Rodriguez, speaking during a plenary on the parliament floor. Photo: Ultimas Noticias.
    May 30, 2023
    Jorge Rodríguez: Far-Right Opposition Exercises Dictatorship at Central University of Venezuela
Tags: Big Pharma capitalism COVID-19 intellectual property Pfizer/BioNTech pharmaceutical companies pharmaceutical industry vaccines World Health Organization (WHO)

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Continue Reading

Previous Previous post:

Cuba Denounces Colombia’s ‘Hostile’ Gesture in the Expulsion of Diplomat

Next Next post:

Colombia: Will the Government Yield?

Subscribe to Our Weekly Newsletter

We keep your data private and share your data only with third parties that make this service possible. Read our Privacy Policy.

Check your inbox or spam folder to confirm your subscription.

NEWS: Most Viewed 72 Hours

Calendar

June 2023
M T W T F S S
 1234
567891011
12131415161718
19202122232425
2627282930  
« May    

Categories

OPINION: Most Viewed 72 hours

We are on Telegram


Receive our news directly in your cellphone or PC, join us on our TELEGRAM channel: https://t.me/OrinocoTribune1

 

Download TELEGRAM, click the link above and then press the JOIN button.

We are on Discord


Now we are also on Discord you will be able to follow our every move and interact with our team.

Join us by clicking here



All our work is free to use and licensed under a Creative Commons Attribution 4.0.

We are on Reddit

If you are more into REDDIT, join our Orinoco Tribune Community.

 

Just click below and then click JOIN
https://www.reddit.com/r/OrinocoTribune/

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Reddit
  • Telegram
  • TikTok
  • LinkedIn
  • Discord
Copyleft, No rights reserved.